Apoptotic cell clearance in systemic lupus erythematosus: II. Role of β2-glycoprotein I

OBJECTIVE To analyze the contribution of beta2-glycoprotein I (beta2-GPI) to apoptotic cell recognition by antiphospholipid antibodies (aPL) and macrophages from patients with autoimmune disease. METHODS Phosphatidylserine expression by Jurkat cells undergoing apoptosis upon CD95 crosslinking or ultraviolet irradiation was verified by confocal microscopy of cells stained with fluorescein isothiocyanate-labeled annexin V. Beta2-GPI was purified by heparin/cationic-exchange chromatography and was biotinylated or used to purify beta2-GPI-specific antibodies by affinity chromatography. Binding to apoptotic cells was assessed by flow cytometry. The clearance of 3H-labeled, apoptotic cells by macrophages was assessed by beta counting. RESULTS The array of epitopes generated by beta2-GPI association with apoptotic cells specifically targets their recognition and is required for their opsonization by human aPL. Nevertheless, beta2-GPI is not required for apoptotic cell clearance by human macrophages in the absence of aPL. CONCLUSION The proinflammatory clearance of aPL-opsonized apoptotic cells, but not the nonphlogistic clearance of apoptotic cells by scavenger macrophages, depends on beta2-GPI.

[1]  J. Davoust,et al.  Apoptotic cell clearance in systemic lupus erythematosus. I. Opsonization by antiphospholipid antibodies. , 1998, Arthritis and rheumatism.

[2]  M. Khamashta,et al.  Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. , 1997, Arthritis and rheumatism.

[3]  Francesca Granucci,et al.  Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures , 1997, The Journal of experimental medicine.

[4]  L. Espinoza,et al.  Induction of Experimental Antiphospholipid Antibody Syndrome in PL/J Mice Following Immunization With β2GPI , 1997, American journal of reproductive immunology.

[5]  A. Tincani,et al.  The anti-beta2-glycoprotein I activity in human anti-phospholipid syndrome sera is due to monoreactive low-affinity autoantibodies directed to epitopes located on native beta2-glycoprotein I and preserved during species' evolution. , 1996, Journal of immunology.

[6]  G. Willems,et al.  Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. , 1996, Biochemistry.

[7]  S Gordon,et al.  Role for the class A macrophage scavenger receptor in the phagocytosis of apoptotic thymocytes in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  A Sali,et al.  Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. , 1996, Journal of immunology.

[9]  C. Haslett,et al.  Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. , 1996, The American journal of pathology.

[10]  A. Tsutsumi,et al.  Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus , 1996 .

[11]  M. Walsh,et al.  Anti-phospholipid autoantibodies bind to apoptotic, but not viable, thymocytes in a beta 2-glycoprotein I-dependent manner. , 1996, Journal of immunology.

[12]  R. Roubey.  Immunology of the antiphospholipid antibody syndrome. , 1996, Arthritis and rheumatism.

[13]  E. Clementi,et al.  CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone gammadelta T cells. , 1996, Journal of immunology.

[14]  M. Petri,et al.  Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Lasala,et al.  Activation of cultured vascular endothelial cells by antiphospholipid antibodies. , 1995, The Journal of clinical investigation.

[16]  C. Reutelingsperger,et al.  Ultrastructural Detection of Surface Exposed Phosphatidylserine on Activated Blood Platelets , 1995, Thrombosis and Haemostasis.

[17]  M. Khamashta,et al.  Epitope specificity of monoclonal anti-beta 2-glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. , 1995, Journal of immunology.

[18]  S. Adelstein,et al.  Immunization of a rabbit with beta 2-glycoprotein I induces charge-dependent crossreactive antibodies that bind anionic phospholipids and have similar reactivity as autoimmune anti-phospholipid antibodies. , 1995, Journal of immunology.

[19]  Y. Shoenfeld,et al.  Early onset of autoimmunity in MRL/++ mice following immunization with β2 glycoprotein I , 1995, Clinical and experimental immunology.

[20]  L. Sammaritano,et al.  Specificities and characteristics of beta 2 glycoprotein I-induced antiphospholipid antibodies. , 1995, The Journal of laboratory and clinical medicine.

[21]  M. Ferrarini,et al.  Daudi lymphoma killing triggers the programmed death of cytotoxic V gamma 9/V delta 2 T lymphocytes. , 1995, Journal of immunology.

[22]  A. Tincani,et al.  Anti-beta 2-glycoprotein I antibodies: a marker of antiphospholipid syndrome? , 1995, Lupus.

[23]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[24]  D. Harrison,et al.  Cell death in health and disease: the biology and regulation of apoptosis. , 1995, Seminars in cancer biology.

[25]  R. Eisenberg,et al.  "Anticardiolipin" autoantibodies recognize beta 2-glycoprotein I in the absence of phospholipid. Importance of Ag density and bivalent binding. , 1995, Journal of immunology.

[26]  R. Roubey.  Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies. , 1994, Blood.

[27]  A. Tincani,et al.  Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. , 1994, The Journal of rheumatology.

[28]  S. Santoro.  Antiphospholipid antibodies and thrombotic predisposition: underlying pathogenetic mechanisms [editorial; comment] , 1994 .

[29]  T. Yasuda,et al.  Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface , 1994, The Journal of experimental medicine.

[30]  J. Hunt,et al.  The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. , 1994, Journal of immunology.

[31]  D. Isenberg,et al.  Immunoelectrophoresis and ELISA techniques for assay of plasma beta 2 glycoprotein-1 and the influence of plasma lipids. , 1993, Thrombosis research.

[32]  S. Pierangeli,et al.  Induction of phospholipid‐binding antibodies in mice and rabbits by immunization with human β2 glycoprotein 1 or anticardiolipin antibodies alone , 1993, Clinical and experimental immunology.

[33]  S. Krilis,et al.  Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  C. Haslett,et al.  Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. , 1992, Journal of immunology.

[35]  J. Buyon,et al.  Lupus anticoagulant activity of autoimmune antiphospholipid antibodies is dependent upon beta 2-glycoprotein I. , 1992, The Journal of clinical investigation.

[36]  T. Sumida,et al.  Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. , 1992, Journal of immunology.

[37]  R. Derksen,et al.  Lupus Anticoagulant Activity Is Frequently Dependent on the Presence of β2-Glycoprotein I , 1992, Thrombosis and Haemostasis.

[38]  M. Raff,et al.  Social controls on cell survival and cell death , 1992, Nature.

[39]  V. Fadok,et al.  Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. , 1992, Journal of immunology.

[40]  Hunt,et al.  A Phospholipid-β2-Glycoprotein I Complex Is an Antigen for Anticardiolipin Antibodies Occurring in Autoimmune Disease But Not with Infection , 1992, Lupus.

[41]  M. Lockshin,et al.  Antiphospholipid antibody syndrome: immunologic and clinical aspects. , 1990, Seminars in arthritis and rheumatism.

[42]  E. Harris,et al.  Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. , 1990, American journal of clinical pathology.

[43]  T. Barbui,et al.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor , 1990, The Lancet.

[44]  C. Chesterman,et al.  Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Santoro,et al.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. , 1990, Annals of internal medicine.

[46]  P. Henson,et al.  Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. , 1987, The Journal of clinical investigation.

[47]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[48]  T. Tomiyama,et al.  A NEW AMINO-COMPOUND IN THE JACK BEAN AND A CORRESPONDING NEW FERMENT.(I) , 1929 .

[49]  S. Shapiro,et al.  The lupus anticoagulant/antiphospholipid syndrome. , 1996, Annual review of medicine.

[50]  M. Bottone,et al.  Etoposide at different concentrations may open different apoptotic pathways in thymocytes. , 1996, European journal of histochemistry : EJH.

[51]  M. Bottone,et al.  A single-step staining procedure for the detection and sorting of unfixed apoptotic thymocytes. , 1993, European journal of histochemistry : EJH.

[52]  C. Haslett,et al.  Phagocyte recognition of cells undergoing apoptosis. , 1993, Immunology today.

[53]  C. Chesterman,et al.  Immunology and clinical importance of antiphospholipid antibodies. , 1991, Advances in immunology.

[54]  D. Mosher.  Physiology of thrombospondin. , 1990, Annual review of medicine.

[55]  G. Kostner,et al.  Investigations on beta 2-glycoprotein-I in the rat: isolation from serum and demonstration in lipoprotein density fractions. , 1980, The International journal of biochemistry.